The scientist’s investigation covers issues in Retinoblastoma, Genetics, Molecular biology, Mutation and Allele. Her Retinoblastoma research entails a greater understanding of Gene. Her study in Molecular biology is interdisciplinary in nature, drawing from both Chromosomal translocation, Psychological repression, Retinoblastoma protein, Promoter and Regulation of gene expression.
Brenda L. Gallie combines subjects such as Genetic counseling, Genotype, Retinal and Germline with her study of Mutation. Her study focuses on the intersection of Allele and fields such as Genome with connections in the field of Esterase D. Her Chromosome 13 research integrates issues from Loss of heterozygosity and Mitotic crossover.
Her primary areas of investigation include Retinoblastoma, Cancer research, Molecular biology, Genetics and Pathology. Retinoblastoma is the subject of her research, which falls under Gene. Her research in Cancer research intersects with topics in Cell culture, Gene expression, Carcinogenesis, Oncogene and Tumor progression.
Her work deals with themes such as Chromosome 13, Retinoblastoma protein and Exon, which intersect with Molecular biology. Mutation, Allele, Germline mutation and Genetic counseling are subfields of Genetics in which her conducts study. Her work in the fields of Chemotherapy, such as Vincristine and Chemotherapy regimen, intersects with other areas such as Intraocular Retinoblastoma.
Brenda L. Gallie mainly focuses on Retinoblastoma, Cancer, Enucleation, Radiology and Internal medicine. She integrates Retinoblastoma with Intraocular Retinoblastoma in her research. The concepts of her Enucleation study are interwoven with issues in Ophthalmology, White matter, Confidence interval and Monocular.
Her research integrates issues of Posterior pole, Trilateral retinoblastoma, Stage and Optic nerve in her study of Radiology. As a part of the same scientific study, Brenda L. Gallie usually deals with the Internal medicine, concentrating on Oncology and frequently concerns with Patient advocacy and Ocular cancer. Her Tumor suppressor gene study is focused on Genetics in general.
Brenda L. Gallie spends much of her time researching Retinoblastoma, Internal medicine, Cancer, Tumor suppressor gene and Oncology. Her Leukocoria study, which is part of a larger body of work in Retinoblastoma, is frequently linked to Intraocular Retinoblastoma, bridging the gap between disciplines. Her Leukocoria study also includes
The Deferiprone, Blood transfusion, Randomized controlled trial and Anemia research she does as part of her general Internal medicine study is frequently linked to other disciplines of science, such as Deferasirox, therefore creating a link between diverse domains of science. Brenda L. Gallie has researched Chemotherapy in several fields, including Hearing loss and Cumulative dose. Her Genetic testing research incorporates themes from Cloning, Suppressor, Gene, Molecular cloning and Computational biology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Expression of recessive alleles by chromosomal mechanisms in retinoblastoma
W. K. Cavenee;W. K. Cavenee;T. P. Dryja;R. A. Phillips;William F Benedict.
Osteosarcoma and retinoblastoma: a shared chromosomal mechanism revealing recessive predisposition
Marc F. Hansen;Alex Koufos;Brenda L. Gallie;Robert A. Phillips.
Proceedings of the National Academy of Sciences of the United States of America (1985)
Genetic origin of mutations predisposing to retinoblastoma.
Webster K. Cavenee;Marc F. Hansen;Magnus Nordenskjold;Eric Kock.
Chemotherapy With Focal Therapy Can Cure Intraocular Retinoblastoma Without Radiotherapy
Brenda L. Gallie;Andrew Budning;Gerrit DeBoer;Jake J. Thiessen.
Archives of Ophthalmology (1996)
Active Surveillance of Small Renal Masses: Progression Patterns of Early Stage Kidney Cancer ☆
Michael A.S. Jewett;Kamal Mattar;Joan Basiuk;Christopher G. Morash.
European Urology (2011)
Using expression profiling data to identify human microRNA targets.
Jim C Huang;Tomas Babak;Timothy W Corson;Timothy W Corson;Timothy W Corson;Gordon Chua.
Nature Methods (2007)
Collaborative Ocular Oncology Group Report Number 1: Prospective Validation of a Multi-Gene Prognostic Assay in Uveal Melanoma
Michael D. Onken;Lori A. Worley;Devron H. Char;James J. Augsburger.
pRb controls proliferation, differentiation, and death of skeletal muscle cells and other lineages during embryogenesis.
E Zacksenhaus;Z Jiang;D Chung;J D Marth.
Genes & Development (1996)
Identification of germline and somatic mutations affecting the retinoblastoma gene.
James M. Dunn;Robert A. Phillips;Andrew J. Becker;Brenda L. Gallie.
Transcriptional repression of the E2-containing promoters EIIaE, c-myc, and RB1 by the product of the RB1 gene.
P A Hamel;R M Gill;R A Phillips;B L Gallie.
Molecular and Cellular Biology (1992)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: